SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-283784"
 

Sökning: id:"swepub:oai:DiVA.org:uu-283784" > Identification of t...

Identification of transformation products from -blocking agents formed in wetland microcosms using LC-Q-ToF

Svan, Alfred (författare)
Uppsala universitet,Avdelningen för analytisk farmaceutisk kemi
Hedeland, Mikael (författare)
Uppsala universitet,Avdelningen för analytisk farmaceutisk kemi,Natl Vet Inst SVA, Dept Chem Environm & Feed Hyg, SE-75189 Uppsala, Sweden.
Arvidsson, Torbjörn (författare)
Uppsala universitet,Avdelningen för analytisk farmaceutisk kemi,Med Prod Agcy, Box 26, SE-75103 Uppsala, Sweden.
visa fler...
Jasper, Justin T. (författare)
Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA.
Sedlak, David L. (författare)
Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA.
Pettersson, Curt E. (författare)
Uppsala universitet,Avdelningen för analytisk farmaceutisk kemi
visa färre...
 (creator_code:org_t)
2016-03-04
2016
Engelska.
Ingår i: Journal of Mass Spectrometry. - : Wiley. - 1076-5174 .- 1096-9888. ; 51:3, s. 207-218
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Identification of degradation products from trace organic compounds, which may retain the biological activity of the parent compound, is an important step in understanding the long-term effects of these compounds on the environment. Constructed wetlands have been successfully utilized to remove contaminants from wastewater effluent, including pharmacologically active compounds. However, relatively little is known about the transformation products formed during wetland treatment. In this study, three different wetland microcosm treatments were used to determine the biotransformation products of the -adrenoreceptor antagonists atenolol, metoprolol and propranolol. LC/ESI-Q-ToF run in the MSE and MS/MS modes was used to identify and characterize the degradation products through the accurate masses of precursor and product ions. The results were compared with those of a reference standard when available. Several compounds not previously described as biotransformation products produced in wetlands were identified, including propranolol-O-sulfate, 1-naphthol and the human metabolite N-deaminated metoprolol. Transformation pathways were significantly affected by microcosm conditions and differed between compounds, despite the compounds' structural similarities. Altogether, a diverse range of transformation products in wetland microcosms were identified and elucidated using high resolving MS. This work shows that transformation products are not always easily predicted, nor formed via the same pathways even for structurally similar compounds.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)

Nyckelord

HRMS
wetland microcosms
transformation products
identification
LC-QToF
metoprolol
atenolol
propranolol

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy